CWM
AERI

Circle Wealth Management’s Aerie Pharmaceuticals AERI Stock Holding History

Circle Wealth Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,240
Closed -$260K – 231
2020
Q4 		$260K Buy
19,240
+1,520
+9% +$18.4K 0.04% 206
2020
Q3 		$209K Buy
17,720
+50
+0.3% +$609 0.03% 195
2020
Q2 		$261K Sell
17,670
-2,700
-13% -$39.9K 0.05% 165
2020
Q1 		$275K Buy
20,370
+1,330
+7% +$25.2K 0.05% 151
2019
Q4 		$460K Buy
+19,040
New +$394K 0.08% 112

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Circle Wealth Management's AERI Position: Q1 2021 in Review

Circle Wealth Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 19,240 shares — an estimated $260K sold.

Circle Wealth Management first reported a position in AERI in Q4 2019 and held it in 5 quarters. The position peaked at $460K in Q4 2019. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.

  • Circle Wealth Management reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Circle Wealth Management sold 19,240 Aerie Pharmaceuticals shares in Q1 2021, an estimated $260K.
  • Circle Wealth Management first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Circle Wealth Management's Aerie Pharmaceuticals position peaked at $460K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.

Based on Circle Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.